News

Net loss of Mangalam Drugs and Organics reported to Rs 13.42 crore in the quarter ended March 2026 as against net profit of Rs 0.06 crore during the previous quarter ended March 2025. Sales declined 7.54% to Rs 67.29 crore in the quarter ended March 2026 as against Rs 72.78 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 44.40 crore in the year ended March 2026 as against net profit of Rs 6.72 crore during the previous year ended March 2025. Sales declined 26.91% to Rs 232.13 crore in the year ended March 2026 as against Rs 317.58 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales67.2972.78 -8 232.13317.58 -27 OPM %-8.3513.60 --6.4211.07 - PBDT-8.616.34 PL -30.3521.39 PL PBT-13.271.63 PL -48.574.79 PL NP-13.420.06 PL -44.406.72 PL Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 26 March 2026.Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News

Net loss of Mangalam Drugs and Organics reported to Rs 9.84 crore in the quarter ended December 2025 as against net profit of Rs 1.29 crore during the previous quarter ended December 2024. Sales declined 34.07% to Rs 58.38 crore in the quarter ended December 2025 as against Rs 88.55 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales58.3888.55 -34 OPM %-2.459.90 - PBDT-5.375.42 PL PBT-9.841.37 PL NP-9.841.29 PL Powered by Capital Market - Live News